Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
VanderWalde, Ari, Bellasea, Shay L., Kendra, Kari L., Khushalani, Nikhil I., Campbell, Katie M., Scumpia, Philip O., Kuklinski, Lawrence F., Collichio, Frances, Sosman, Jeffrey A., Ikeguchi, Alexandra, Victor, Adrienne I., Truong, Thach-Giao, Chmielowski, Bartosz, Portnoy, David C., Chen, Yuanbin, Margolin, Kim, Bane, Charles, Dasanu, Constantin A., Johnson, Douglas B., Eroglu, Zeynep, Chandra, Sunandana, Medina, Egmidio, Gonzalez, Cynthia R., Baselga-Carretero, Ignacio, Vega-Crespo, Agustin, Garcilazo, Ivan Perez, Sharon, Elad, Hu-Lieskovan, Siwen, Patel, Sapna P., Grossmann, Kenneth F., Moon, James, Wu, Michael C., Ribas, Antoni
Published in Nature medicine (01.09.2023)
Published in Nature medicine (01.09.2023)
Get full text
Journal Article
Randomized phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922
Overman, Michael J., Guthrie, Katherine A, Salem, Mohamed E., Pedersen, Katrina Sophia, Kalyan, Aparna, Bellasea, Shay, Philip, Philip Agop
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAF V600E metastatic and/or unresectable colorectal cancer: SWOG S2107
Morris, Van K., Guthrie, Katherine A, Kopetz, Scott, Breakstone, Rimini, Karasic, Thomas Benjamin, Hu, Zishuo Ian, Bellasea, Shay, Fakih, Marwan, Gholami, Sepideh, Gold, Philip Jordan, Philip, Philip Agop
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513
Chiorean, E Gabriela, Guthrie, Katherine A, Philip, Philip A, Swisher, Elizabeth M, Jalikis, Florencia, Pishvaian, Michael J, Berlin, Jordan, Noel, Marcus S, Suga, Jennifer M, Garrido-Laguna, Ignacio, Cardin, Dana Backlund, Radke, Marc R, Duong, Mai, Bellasea, Shay, Lowy, Andrew M, Hochster, Howard S
Published in Clinical cancer research (01.12.2021)
Published in Clinical cancer research (01.12.2021)
Get full text
Journal Article
Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104
Soares, Heloisa P., Guthrie, Katherine A, Ahmad, Syed A., Washington, Mary Kay, Ramnaraign, Brian Hemendra, Raj, Nitya Prabhakar, Seigel, Carole, Bellasea, Shay, Chiorean, E. Gabriela, Dasari, Arvind, Strosberg, Jonathan R., Eng, Cathy, Philip, Philip Agop
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Abstract 6550: Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma
Campbell, Katie M., Bustami, Zaid, Chen, Daniel G., Medina, Egmidio, Gonzalez, Cynthia R., Aldeen, Nataly Naser, Baselga-Carretero, Ignacio, Vega-Crespo, Agustin, Maxey, Jessica, Chen, Jia M., Kuklinski, Lawrence F., Kendra, Kari L., Chmielowski, Bartosz, Truong, Thach-Giao, Khushalani, Nikhil I., Collichio, Frances, Ikeguchi, Alexandra, Victor, Adrienne I., Margolin, Kim, Sosman, Jeffrey A., Patel, Sapna P., Hu-Lieskovan, Siwen, Moon, James, Bellasea, Shay, Wells, Daniel K., Spencer, Christine N., Thompson, Marshall A., Wu, Michael, Scumpia, Philip O., VanderWalde, Ari, Ribas, Antoni
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract CT009: S1512: High response rate with single agent anti-PD-1 in patients with metastatic desmoplastic melanoma
Kendra, Kari, Bellasea, Shay, Eroglu, Zeynep, Hu-Lieskovan, Siwen, Campbell, Katie M., Carson, William, Wada, David, Plaza, Jose A., Sosman, Jeffrey, IN, Gino K., Ikeguchi, Alexandra, Hyngstrom, John, Brohl, Andres, Khushalani, Nikhil I., Markowitz, Joseph, Negrea, George, Kasbari, Samer, Doolittle, Gary C., Swami, Umang, Roberts, Toni, Patel, Sapna P., Sharon, Elad, Moon, James, Wu, Michael C., Ribas, Antoni
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
Abstract 3275: Combination of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in advanced melanoma patients following progression on a prior PD-1 inhibitor: SWOG S1607
Hu-Lieskovan, Siwen, Moon, James, Hyngstrom, John, Campbell, Katie M., In, Gino K., Logan, Theodore F., Kendra, Kari L., Wang, Ding M., Johnson, Douglas B., Doolittle, Gary C., Tan, Alan, Silk, Ann W., Grossmann, Kenneth F., Ryan, Christopher W., Patel, Sapna P., Bellasea, Shay, Wu, Michael C., Kirkwood, John M., Chen, Helen X., Ribas, Antoni
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 4527: CD8 T cell-melanoma cell interactions in response and resistance to ipilimumab plus nivolumab: Biopsy analysis of SWOG S1616
Campbell, Katie M., Kuklinski, Lawrence, Bustami, Zaid, Maxey, Jessica, Medina, Egmidio, Santulli-Marotto, Sandra, Gonzalez, Cynthia R., Aldeen, Nataly Naser, Kendra, Kari, Patel, Sapna, Hu-Lieskovan, Siwen, Moon, James, Bellasea, Shay, Spencer, Christine N., Thompson, Marshall A., Wu, Michael, Vanderwalde, Ari, Scumpia, Philip O., Ribas, Antoni
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article